Abstract Introduction Type 1 diabetes (T1D) is a progressive autoimmune disease with identifiable presymptomatic stages. Islet autoantibody screening, expanded in Italy by Law 130/2023, identifies children and adults at high risk of progression. Structured longitudinal follow-up is needed to characterise disease trajec...
V. Cherubini, R. Gesuita, E. Mozzillo et al.· BMJ Open· 0 citations
BACKGROUND
Paediatric type 1 diabetes (T1D) is a chronic disease that represents a global public health concern. Italian data describing epidemiology, comorbidity burden, and healthcare resource utilisation (HCRU) of paediatric T1D remain fragmented, mostly deriving from regional registries or limited cohorts.
METHOD...
E. Mozzillo, C. Trimarchi, R. Buzzetti et al.· Acta Diabetologica· 0 citations
These recommendations, revised and approved by the Italian National Institute of Health, aim to provide clinicians with a structured and evidence-based approach to improve the early identification, diagnostic work-up, and management of pediatric patients with bone fragility, promoting standardized care and reducing var...
L. de Sanctis, G. Baroncelli, B. Pintaudi et al.· Italian Journal of Pediatric...· 0 citations
CGM is safe in very young children, with AID systems proving superior to traditional therapy, and real-world evidence supports incorporating AID consideration into future international guidelines from the time of pediatric diagnosis.
M. Marigliano, A. Scaramuzza, C. Arnaldi et al.· Diabetes Technology & Therap...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.